The global neglected tropical disease treatment market is anticipated to expand at a substantial CAGR during forecast period, between 2020 and 2027. Neglected tropical diseases are commonly seen in the areas where people do not have access to clean water or safe ways to dispose human waste.
Neglected tropical disease (NTD) refers to a heterogeneous and diverse group of communicable diseases that prevail in the subtropical and tropical conditions in around 149 countries. These diseases are caused by pathogens such as bacteria, protozoa, viruses, and helminthes. NTDs can be prevented by controlling the vectors transmitting diseases such as black flies and mosquitoes and by maintaining sanitation & hygiene. NTDs are concentrated in settings of extreme poverty in urban slums, remote rural areas, and conflict zones in Africa, Latin America, and Asia.
Market Trends, Drivers, Restraints, and Opportunities:
- Rising government initiatives against NTDs is expected to boost the market during the forecast period.
- Growing burden of NTDs in tropical and subtropical countries globally is propelling the market growth.
- Low healthcare budget and limited operating revenue opportunities for research & development of targeted therapies are anticipated to impede the neglected tropical disease treatment market in the coming years.
- High demand for disease specific novel treatments is providing opportunities in the market.
Scope of the report:
The report on neglected tropical disease treatment market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.
Asia Pacific, North America, Europe, Latin America, and Middle East & Africa
Market scope, analysis, share, competitive analysis, growth facts, restraints, opportunities and revenue forecast
Neglected Tropical Disease Treatment Market Segment Insights:
Rising R&D activities for Chagas disease treatment drives segment growth
In terms of disease types, the global neglected tropical disease treatment market can be categorized as Mediterranean fever, Ebola virus infection, Chagas disease, Zika virus infection, Chikungunya, and others. The Chagas disease segment held a substantial share of the market share in 2019 and is anticipated to expand at a moderate CAGR during the forecast period due to factors such as rising research activities for the development of Chagas disease treatments and growing occurrence of the disease owing to unhygienic conditions. Moreover, approvals for novel products used to treat the disease are expected to propel segmental growth in the near future.
Presence of pipeline products to propel segmental growth
Based on treatment types, the market can be bifurcated into drugs and vaccine. The drugs segment is sub-divided into analgesics, antipyretics, antibiotics, and others. The vaccine segment is sub-segmented into dengvaxia, mosquirix, and others. The vaccines segment is anticipated to expand at a high CAGR during the forecast period owing to the presence of pipeline products and increasing focus of market players to develop vaccines for NTDs.
Awareness about the advantages of oral route of administration boosts segment growth
On the basis of routes of administration, the global neglected tropical disease treatment market can be classified as oral and injectable. The oral segment dominated the market in 2019 and is projected to expand at a high CAGR during the forecast period due patient compliance, ease of ingestion, pain avoidance, safety, and versatility to accommodate various types of drugs.
Access to a large patient pool in hospitals propels the segment
In terms of end-users, the market can be divided into hospitals, homecare, specialty clinics, and others. The hospitals segment is anticipated to expand at a substantial CAGR during the forecast period due to the availability of superior medical treatments for NTDs in hospitals. Moreover, hospitals provide cater to large patient pool.
Retail pharmacies segment accounts for a dominant share of the market
On the basis of distribution channels, the market can be segmented into hospital pharmacies, retail pharmacies, and others. Retail pharmacies segment is projected to be a lucrative segment of the market during the forecast period. In retail pharmacies, pharmacists interact with the patients to provide targeted counseling. This results in a better experience for the customer, hence most people tend to purchase their medications from retail pharmacy.
Asia Pacific is expected to account for a significant share of the global market
Based on regions, the global neglected tropical disease treatment market is fragmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. Asia Pacific is expected to account for a large share of the market owing to factors such as continuously increasing GDP, presence of a large target population, and high prevalence of neglected tropical diseases in this region.
By Disease Types
- Mediterranean Fever
- Ebola Virus Infection
- Chagas Disease
- Zika Virus Infection
By Treatment Types
By Routes of Administration
- Specialty Clinics
By Distribution Channels
- Hospital Pharmacies
- Retail Pharmacies
- North America
- Latin America
- Asia Pacific
- Middle East & Africa
Key players in the global neglected tropical disease treatment market includes Emergent BioSolutionsInc, Moderna, Valneva SE, Johnson & Johnson Services, Inc, DAIICHI SANKYO COMPANY, LIMITED, InsudPharma group, Humanigen, Inc, Savant HWP, Inc, Bayer AG, Eisai Co., Ltd, Oblita Therapeutics, GlaxoSmithKline plc, Themis Bioscience GmbH, Novartis AG, and Amneal Pharmaceuticals LLC. Collaborations, mergers, acquisitions, agreements, and partnerships are strategies adopted by these players to strengthen their geographical presence.